Jonathan Zalevsky

Jonathan Zalevsky currently serves as the Chief Research & Development Officer at Nektar Therapeutics, a position held since July 2015. Prior to this role, Jonathan was the Vice President and Head of Immunology Research at Takeda from October 2009 to July 2015, and also held the title of Director at Xencor from June 2002 to September 2009. Jonathan Zalevsky earned a Doctor of Philosophy (PhD) in Biochemistry from the University of California, San Francisco, from 1998 to 2002.